| abstract |
A method of screening a compound or a salt thereofnthat alters the binding property of Neuromedin U withnFM-3, characterized by using Neuromedin U, a derivativenthereof or a salt thereof and FM-3 or a salt thereof ofnthe present invention, can be used for screening antherapeutic and/or prophylactic agent for hypertensionnor stress-related diseases. A FM-3 antagonist is usefulnas a therapeutic and/or prophylactic agent fornhypertension or stress-related diseases. |